Harvard Bioscience, Inc. (HBIO) Q2 2026 Earnings Call Transcript
Harvard Bioscience, Inc. (HBIO) Q2 2026 Earnings Call Transcript
Harvard Bioscience, Inc. (HBIO) Q1 2026 Earnings Call Transcript
Harvard Bioscience, Inc. (HBIO) Q1 2026 Earnings Call Transcript
Harvard Bioscience Q4 Earnings Call Highlights
Harvard Bioscience (NASDAQ: HBIO) executives highlighted a year of "foundation building" and cost and balance sheet actions while outlining expectations for a return to growth in 2026 during the company's fourth-quarter and full-year 2025 earnings call. Management points to refinancing, manufacturing consolidation, and governance changes President and CEO John Duke said 2025 represented a "pivotal year
Harvard Bioscience, Inc. (HBIO) Q4 2025 Earnings Call Transcript
Harvard Bioscience, Inc. (HBIO) Q4 2025 Earnings Call Transcript
Jeffrey Epstein files: Larry Summers steps back from public commitments over email fallout
Former Treasury Secretary Larry Summers said he was stepping back from all public commitments amid fallout from the release of emails between him and sex offender Jeffrey Epstein. "I am deeply ashamed of my actions and recognize the pain they have caused.
Harvard Bioscience, Inc. (HBIO) Q3 2025 Earnings Call Transcript
Harvard Bioscience, Inc. ( HBIO ) Q3 2025 Earnings Call November 6, 2025 8:00 AM EST Company Participants John Duke - President, CEO & Director Mark Frost - Interim CFO, Treasurer, Principal Financial Officer & Principal Accounting Officer Conference Call Participants Taylor Krafchik Lucas Baranowski - KeyBanc Capital Markets Inc., Research Division Bruce Jackson - The Benchmark Company, LLC, Research Division Presentation Operator Good day, and welcome to the Third Quarter 2025 Harvard Bioscience Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded.
Harvard Bioscience, Inc. (HBIO) Q2 2025 Earnings Call Transcript
Harvard Bioscience, Inc. (NASDAQ:HBIO ) Q2 2025 Earnings Conference Call August 11, 2025 8:00 AM ET Company Participants John Duke - President, CEO & Director Mark T. Frost - Interim CFO, Treasurer, Principal Financial Officer & Principal Accounting Officer Conference Call Participants Bruce David Jackson - The Benchmark Company, LLC, Research Division Paul Richard Knight - KeyBanc Capital Markets Inc., Research Division Taylor Krafchik - Unidentified Company Operator Good day, and welcome to the Second Quarter 2025 Harvard Bioscience Earnings Conference Call.
Harvard Bioscience, Inc. (HBIO) Q1 2025 Earnings Call Transcript
Harvard Bioscience, Inc. (NASDAQ:HBIO ) Q1 2025 Earnings Conference Call May 12, 2025 8:00 AM ET Company Participants Kathryn Flynn - Corporate Controller Jim Green - Chairman, President & CEO Mark Frost - Interim CFO Conference Call Participants Paul Knight - KeyBanc Bruce Jackson - The Benchmark Company Operator Good day, and welcome to the First Quarter 2025 Harvard Bioscience Inc Earnings Conference Call. All participants will be in a listen-only mode.
Harvard Bioscience, Inc. (HBIO) Q4 2024 Earnings Call Transcript
Harvard Bioscience, Inc. (NASDAQ:HBIO ) Q4 2024 Results Conference Call March 12, 2025 8:00 AM ET Company Participants Kathryn Flynn - Corporate Controller Jim Green - Chairman, President & CEO Jennifer Cote - CFO & Treasurer Conference Call Participants Paul Knight - KeyBanc Bruce Jackson - The Benchmark Company Operator Good day, and welcome to the Fourth Quarter 2024 Harvard Bioscience Earnings Conference Call. At this time, all participants are in listen-only mode.
Harvard Bioscience, Inc. (HBIO) Q3 2024 Earnings Call Transcript
Harvard Bioscience, Inc. (NASDAQ:HBIO ) Q3 2024 Results Conference Call November 7, 2024 8:00 AM ET Company Participants Kathryn Flynn - Corporate Controller James Green - Chairman, President and CEO Jennifer Cote - CFO Conference Call Participants Paul Knight - KeyBanc Bruce Jackson - The Benchmark Company Operator Good day, and welcome to the Third Quarter 2024 Harvard Biosciences Inc. Earnings Conference Call. [Operator Instructions] As a reminder, this call may be recorded.
2 Instruments Stocks to Watch From a Challenging Industry
The Zacks Instruments - Scientific industry participants like MTD and HBIO are gaining from strong life science, pharmaceutical and academic end-market demand despite the challenging macroeconomic environment.
Harvard Bioscience, Inc. (HBIO) Q2 2024 Earnings Call Transcript
Harvard Bioscience, Inc. (NASDAQ:HBIO ) Q2 2024 Earnings Conference Call August 8, 2024 10:00 AM ET Company Participants Kathryn Flynn - Corporate Controller James Green - Chairman, President and CEO Jennifer Cote - CFO Conference Call Participants Paul Knight - KeyBanc Capital Markets Bruce Jackson - The Benchmark Company Christopher Sakai - Singular Research Operator Good day, and thank you for standing by. Welcome to the Q2 2024 Harvard Bioscience, Inc. Earnings Conference Call.
